Estrogen replacement therapy and coronary heart disease in postmenopausal women
- 1 May 1996
- journal article
- review article
- Published by Taylor & Francis in Health Care for Women International
- Vol. 17 (3) , 247-254
- https://doi.org/10.1080/07399339609516239
Abstract
My purpose in writing this paper is to explicate the current state of knowledge regarding estrogen replacement therapy when prescribed for prophylaxis of coronary heart disease in women. There is controversy in the literature surrounding the nature of estrogen replacement research, its findings, and the advisability of practitioners using these findings for practice. In this article this controversy is explored and recommendations for practice are made.Keywords
This publication has 16 references indexed in Scilit:
- Cardiovascular Risk at the Menopause – Role of Sexual SteroidsHormone Research, 1995
- Feminist Empiricism as a Method for Inquiry in NursingWestern Journal of Nursing Research, 1994
- Postmenopausal Hormone Replacement Therapy, Coronary Heart Disease and Plasma LipoproteinsDrugs, 1994
- Hormone replacement therapy: the need for reconsideration.American Journal of Public Health, 1993
- Postmenopausal Hormone-Replacement TherapyNew England Journal of Medicine, 1993
- Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal WomenNew England Journal of Medicine, 1993
- Estrogen and coronary heart disease in womenPublished by American Medical Association (AMA) ,1991
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Coronary heart disease in women: Special considerationsCurrent Problems in Cardiology, 1988
- Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.Circulation, 1987